Final Results
AstraZeneca9 February 2023 07:00 GMT Full year and Q4 2022 results Strong performance and pipeline progress in 2022 underpins 2023 outlookOn track to deliver industry-leading revenue growth through 2025 and beyond Revenue and EPS summary [][][][] FY 2022 Q4 2022 % Change % Change $m Actual CER[[1]] $m Actual CER - Product Sales 42,998 18 24 10,798 (6) 2 -